Robert Korngold on Advances in Bone Marrow Transplant

Robert Korngold, PhD
Published: Saturday, Feb 25, 2017



Robert Korngold, PhD, chief of The Division of Research at John Theurer Cancer Center, reflects on the progress made in the field of bone marrow transplant. Most strikingly, new approaches have opened the opportunity of a bone marrow transplant to virtually all eligible patients, he noted.

Bone marrow transplants have become the platform from which immunotherapy and vaccines can be built, Korngold believes. New methods and approaches are becoming available, which lend strength to the graph versus tumor response in the hope of avoiding relapses and complications.

<<< View more from the 2017 BMT Tandem Meetings


Robert Korngold, PhD, chief of The Division of Research at John Theurer Cancer Center, reflects on the progress made in the field of bone marrow transplant. Most strikingly, new approaches have opened the opportunity of a bone marrow transplant to virtually all eligible patients, he noted.

Bone marrow transplants have become the platform from which immunotherapy and vaccines can be built, Korngold believes. New methods and approaches are becoming available, which lend strength to the graph versus tumor response in the hope of avoiding relapses and complications.

<<< View more from the 2017 BMT Tandem Meetings

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Cancer Summaries and Commentaries™: Update from Chicago: Advances in the Treatment of Breast CancerJul 31, 20181.0
Community Practice Connections™: The Next Generation in Renal Cell Carcinoma Treatment: An Oncology Nursing Essentials WorkshopJul 31, 20181.5
Publication Bottom Border
Border Publication
x